Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Equipment
Research output
Prizes
Activities
Search by expertise, name or affiliation
A mimotope peptide-based anti-cancer vaccine selected by BAT monoclonal antibody
Britta Hardy
*
, Annat Raiter
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A mimotope peptide-based anti-cancer vaccine selected by BAT monoclonal antibody'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
BAT monoclonal antibody
100%
Cancer Vaccines
54%
Peptides
28%
Peptide Library
24%
Anti-Idiotypic Antibodies
15%
Immunization
15%
peptide B
14%
peptide A
13%
Neoplasm Antibodies
12%
Isoleucine
11%
Proline
9%
Bacteriophages
8%
Arginine
8%
Antibody Formation
8%
Immunoglobulin G
6%
Ligands
6%
Amino Acids
6%
Antibodies
5%
Growth
4%
Serum
4%
Neoplasms
2%
Agriculture & Biology
cancer vaccines
84%
monoclonal antibodies
40%
peptides
30%
peptide libraries
23%
phages
20%
antibodies
19%
humoral immunity
16%
immunization
14%
neoplasms
11%
mice
8%
isoleucine
7%
ligands
6%
arginine
6%
proline
6%
receptors
5%
cells
4%
amino acids
4%
Social Sciences
cancer
41%
interaction
10%